A Phase 1 Study to Evaluate the Effect of Food and Age on the Pharmacokinetics of LPM526000133 Fumarate Capsules (LY03017) in Healthy Volunteers
Latest Information Update: 04 Feb 2025
Price :
$35 *
At a glance
- Drugs LY 03017 (Primary)
- Indications Schizophrenia
- Focus Pharmacokinetics
- Sponsors Luye Pharma Group
- 04 Feb 2025 New trial record